RE:RE:RE:RE:RE:biorun, you loserAre you reading ok?
There is a difference between the upfront payment and cash flow to sustain operations without financing. The two are related but the upfront payment is not the only source of money. I also started the day by saying the next few days were an opportunity, not just today.
First principle, nobody knows what the upfront payment is. If you think its going to be enough to make a big difference then you are decieving yourself.
I have said on many occasions that, according to historical information, there is a grant from the French Government to support fluorination chemistry, and as well the upfront payment, whatever that is. Between these two, I would be surprised if they needed additional cash.
I highly doubt R&F will produce additional revenue, but since they were zero for 2 quarters, perhaps that is also possible that they place another order and a little cash accrues there.
I think you haven't been taking the cues here that nobody expects the upfront to be surprising in a positive way. Sleepyhoward even said the other day $1 million. A few smart ones on the German boards say the same thing and have been for months based upon their experiences.
The play here is really to take advantage of the weak hands and buy shares when others are selling. This too shall pass and we will be talking about Anti-aging and Pets deals soon enough.
Lots on the go.